Concepedia

Publication | Open Access

PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma

31

Citations

27

References

2020

Year

Abstract

PTEN may be a biomarker and therapeutic target in patients with metastatic RCC.

References

YearCitations

Page 1